Bio-Path Holdings, Inc. Reports Third Quarter 2012 Operational and Financial Results

Published: Nov 16, 2012

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc., (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the quarter ended September 30, 2012.

Back to news